Food and Drug Administration (FDA)

Stop sign
Biotech

FDA puts Intellia CRISPR trials on hold over raised liver enzyme

After Intellia paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the FDA has made things official.
James Waldron Oct 30, 2025 6:37am
Lab mouse in a transparent glass tube

Former FDA deputy to guide Charles River animal testing strategy

Oct 15, 2025 10:00am
Clock in front of the subway

Denali's Hunter syndrome drug latest to be hit by FDA delay

Oct 14, 2025 8:09am
Marks

Former FDA official Peter Marks joins Eli Lilly

Oct 7, 2025 3:49pm
Space shuttle takes off on background of blue sky

Rocket aborts mission to get rare disease gene therapy approved

Oct 3, 2025 9:30am
Layoffs

IO lays off 50% after FDA derails cancer vaccine approval plan

Sep 29, 2025 8:55am